Adipose tissue hypoxia, inflammation, and fibrosis in obese insulin-sensitive and obese insulin-resistant subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 4, 2016, Pages 1422-1428

  Lawler, Helen M ^a   Underkofler, Chantal M ^a   Kern, Philip A ^b   Erickson, Christopher ^a   Bredbeck, Brooke ^a   Rasouli, Neda ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Veterans Administration Eastern Colorado Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CD68 ANTIGEN; COLLAGEN TYPE 6; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEPTIN; MATRILYSIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SCAVENGER RECEPTOR A; TUMOR NECROSIS FACTOR; VASCULOTROPIN; ANTIDIABETIC AGENT; INSULIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY FAT; BODY MASS; CD68 GENE; COLLAGEN VI GENE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FIBROSIS; GENE CONTROL; GENE EXPRESSION; HIF1A GENE; HUMAN; HYPOXEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIMIT OF QUANTITATION; MALE; MCP1 GENE; MMP7 GENE; OBESITY; OXIDIZED LDL RECEPTOR 1 GENE; PATHOGENESIS; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; SCAVENGER RECEPTOR A GENE; TISSUE OXYGENATION; UPREGULATION; VEGF GENE; COHORT ANALYSIS; COMPLICATION; HYPOXIA; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADIPOSE TISSUE; ADULT; COHORT STUDIES; FEMALE; FIBROSIS; HUMANS; HYPOGLYCEMIC AGENTS; HYPOXIA; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; YOUNG ADULT;

EID: 85011278150     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-4125     Document Type: Article

References (31)

1. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012;97(7):2482-2488.
2. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol. 2010;21(1):38-43.
3. Phillips C. Metabolically healthy obesity: Definitions, determinants and clinical implications. Rev Endocr Metab Disord. 2013;14(3):219-227.
4. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121(6):2094-2101.
5. McLaughlin T, Deng A, Gonzales O, et al. Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women. Diabetologia. 2008;51(12):2303-2308.
6. O'Connell J, Lynch L, Hogan A, Cawood TJ, O'Shea D. Preadipocyte factor-1 is associated with metabolic profile in severe obesity. J Clin Endocrinol Metab. 2011;96(4):E680-E684.
7. Xu XJ, Gauthier MS, Hess DT, et al. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J Lipid Res. 2012;53(4):792-801.
8. Pasarica M, Sereda OR, Redman LM, et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2009;58(3):718-725.
9. Wood IS, de Heredia FP, Wang B, Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc. 2009;1-8.
10. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond). 2009;33(1):54-66.
11. Hosogai N, Fukuhara A, Oshima K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 2007;56(4):901-911.
12. Regazzetti C, Peraldi P, Gremeaux T, et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes. 2009;58(1):95-103.
13. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol Endocrinol Metab. 1979;236(6):E667-E677.
14. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. 2003;5(6):1003-1015.
15. Di Gregorio GB, Yao-Borengasser A, Rasouli N, et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes. 2005;54(8):2305-2313.
16. Rasouli N, Yao-Borengasser A, Varma V, et al. Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb Vasc Biol. 2009;29(9):1328-1335.
17. Yao-Borengasser A, Rassouli N, Varma V, et al. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness. J Clin Endocrinol Metab. 2008;93(11):4431-4439.
18. Spencer M, Unal R, Zhu B, et al. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab. 2011;96(12):E1990-E1998.
19. Yao-Borengasser A, Varma VF, Coker RH, et al. Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone. Metabolism. 2011;60(7):1012-1020.
20. Varma V, Yao-Borengasser A, Bodles AM, et al. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes. 2008;57(2):432-439.
21. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 2008;93(11 suppl 1):S64-S73.
22. Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55(9):2319-2326.
23. Khan T, Muise ES, Iyengar P, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol. 2009;29(6):1575-1591.
24. Spencer M, Yao-Borengasser A, Unal R, et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab. 2010;299(6):E1016-E1027.
25. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes. 2002;51(4):1093-1101.
26. Goossens GH, Blaak EE. Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen? Front Endocrinol (Lausanne). 2015;6:55.
27. Lackey DE, Burk DH, Ali MR, et al. Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity - fibrosis and adipose tissue dysfunction. Am J Physiol Endocrinol Metab. 2014;306(3):E233-E246.
28. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280(5):E745-E751.
29. Ruhl CE, Everhart JE. Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr. 2001;74(3):295-301.
30. Eltzschig HK, Carmeliet P. Hypoxia and Inflammation. N Engl J Med. 2011;364(7):656-665.
31. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013;93(1):1-21.